Drug Shortage Report for MINT-TOPIRAMATE
| Report ID | 28570 |
| Drug Identification Number | 02315653 |
| Brand name | MINT-TOPIRAMATE |
| Common or Proper name | Mint- Topiramate |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOPIRAMATE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | Bottles of 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2017-11-07 |
| Estimated end date | 2017-12-15 |
| Actual end date | 2017-12-15 |
| Shortage status | Resolved |
| Updated date | 2018-01-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-01-04 | French | Compare |
| v6 | 2018-01-04 | English | Compare |
| v5 | 2017-12-15 | French | Compare |
| v4 | 2017-12-15 | English | Compare |
| v3 | 2017-11-08 | English | Compare |
| v2 | 2017-11-07 | French | Compare |
| v1 | 2017-11-07 | English | Compare |
Showing 1 to 7 of 7